Schering-plough Animal Health Corporation

Schering Corporation

Intervet Inc.

David G Sawutz

Kevin Norman Winzenberg

Andris Juris Liepa

Ashit K Ganguly

Deen Tulshian

Ginny Dai Ho

Ana Bercovici

Adam Gerhardt Meyer

Philippe Brianceau

Adam Gerhard Meyer

Craig L Francis

Simon Saubern

Novel trifluoromethanesulfonanilide oxime ether compounds useful for controlling endo and/or ectoparasites in the environment are provided, together with methods of making the same, and methods of using the inventive compounds to treat parasite infestations in vivo or ex vivo.

Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives

Novel imidazo[1,2-b]pyridazine compounds useful for controlling parasites in animals and methods of treatment of parasite infestation in animals using the compounds are disclosed.

Control of parasites in animals by the use of imidazo[1,2-b]pyridazine derivatives

2-Phenyl-3-(1H-pyrrol-2-yl)acrylonitrile compounds useful for controlling parasites in animals and methods of treatment of parasite infestation in animals using the compounds are disclosed.

Control of parasites in animals by the use of parasiticidal 2-phenyl-3-(1H-pyrrol-2-yl)acrylonitrile derivatives

The compound of the formula or a pharmaceutically acceptable salt or solvate thereof, pharmaceutical compositions therefore, and the use of said compounds as nociceptin receptor inhibitors useful in the treatment of anxiety are disclosed.

High affinity ligands for nociceptin receptor ORL-1

Growing community of inventors

Maplewood, NJ, United States of America

David G Sawutz